Director Dealings

RNS Number : 0588U

Eco Animal Health Group PLC

30 November 2021

 

30 November 2021

ECO Animal Health Group PLC

("ECO" or "the Company")

Directors Dealings

ECO Animal Health Group plc was notified today that on 30 November 2021 the following Director purchases of ordinary shares of 5p each in the capital of the Company ("Ordinary Shares") were made.

Marc Loomes, Chief Executive Officer of the Company, purchased 33,244 Ordinary Shares at a price of 150.40 pence per Ordinary Share. As a result of this transaction, Marc Loomes' total shareholding in the Company comprises 33,244 Ordinary Shares, representing approximately 0.05 per cent. of the Company's issued share capital.

Christopher Wilks, Chief Financial Officer of the Company, purchased 16,595 Ordinary Shares at a price of 150.64 pence per Ordinary Share. As a result of this transaction, Christopher Wilks' total shareholding in the Company comprises 24,095 Ordinary Shares, representing approximately 0.04 per cent. of the Company's issued share capital.

 Contacts:

ECO Animal Health Group plc Marc Loomes (CEO) Christopher Wilks (CFO)	020 8447 6906
IFC Advisory Graham Herring Zach Cohen	020 3934 6630
Singer Capital Markets (Nominated Adviser & Joint Broker) Mark Taylor George Tzimas	020 7496 3000
Peel Hunt LLP (Joint Broker) James Steel Dr Christopher Golden	020 7418 8900
Equity Development Hannah Crowe Matt Evans	020 7065 2692

About ECO Animal Health

ECO Animal Health Group plc ("ECO" or "the Group") researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products

PDMR Notification

The notification below is made in accordance with the requirements of MAR

Acquisition of Ordinary Shares

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	Marc Loomes
2.	Reason for the notification
a.	Position/status	Chief Executive Officer
b.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Eco Animal Health Group Plc
b.	LEI	2138009XN9DJ3YP70B55
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 5p each. GB0032036807
b.	Nature of the transaction	Acquisition of Ordinary Shares
c.	Price(s) and volume(s)	Price(s) Volume(s) 150.40p 33,244
d.	Aggregated information Aggregated volume Price	n/a
e.	Date of the transaction	30 November 2021
f.	Place of the transaction	London Stock Exchange, AIM Market (XLON)

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	Christopher Wilks
2.	Reason for the notification
a.	Position/status	Chief Financial Officer
b.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Eco Animal Health Group Plc
b.	LEI	2138009XN9DJ3YP70B55
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 5p each. GB0032036807
b.	Nature of the transaction	Acquisition of Ordinary Shares
c.	Price(s) and volume(s)	Price(s) Volume(s) 150.64p 16,595
d.	Aggregated information Aggregated volume Price	n/a
e.	Date of the transaction	30 November 2021
f.	Place of the transaction	London Stock Exchange, AIM Market (XLON)

 

END

 

 

DSHFZMFMZGKGMZM